Literature DB >> 26691725

Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?

Carissa Kuswanto1, Rowena Chin1, Min Yi Sum1, Somnath Sengupta2, Andrea Fagiolini3, Roger S McIntyre4, Eduard Vieta5, Kang Sim6.   

Abstract

Recent data from genetic and brain imaging studies have urged rethinking of bipolar disorder (BD) and schizophrenia (SCZ) as lying along a continuum of major endogenous psychoses rather than dichotomous disorders. We systematically reviewed extant studies (from January 2000 to July 2015) that directly compared neurocognitive impairments in adults with SCZ and BD. Within 36 included studies, comparable neurocognitive impairments were found in SCZ and BD involving executive functioning, working memory, verbal fluency and motor speed. The extent and severity of neurocognitive impairments in patients with schizoaffective disorder, and BD with psychotic features occupy positions intermediate between SCZ and BD without psychotic features, suggesting spectrum of neurocognitive impairments across psychotic spectrum conditions. Neurocognitive impairments correlated with socio-demographic (lower education), clinical (more hospitalizations, longer duration of illness, negative psychotic symptoms and non-remission status), treatment (antipsychotics, anti-cholinergics) variables and lower psychosocial functioning. The convergent neurocognitive findings in both conditions support a continuum concept of psychotic disorders and further research is needed to clarify common and dissimilar progression of specific neurocognitive impairments longitudinally.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Neurocognitive impairments; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26691725     DOI: 10.1016/j.neubiorev.2015.12.002

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  16 in total

1.  A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses.

Authors:  Faith M Hanlon; Ronald A Yeo; Nicholas A Shaff; Christopher J Wertz; Andrew B Dodd; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Swala Abrams; Jingyu Liu; Andrew R Mayer
Journal:  Schizophr Res       Date:  2019-01-31       Impact factor: 4.939

2.  Transdiagnostic Multimodal Neuroimaging in Psychosis: Structural, Resting-State, and Task Magnetic Resonance Imaging Correlates of Cognitive Control.

Authors:  Dov B Lerman-Sinkoff; Sridhar Kandala; Vince D Calhoun; Deanna M Barch; Daniel T Mamah
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-05-20

Review 3.  Impact of juvenile chronic stress on adult cortico-accumbal function: Implications for cognition and addiction.

Authors:  Michael J Watt; Matthew A Weber; Shaydel R Davies; Gina L Forster
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-06-19       Impact factor: 5.067

4.  Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.

Authors:  A M Sánchez-Torres; L Moreno-Izco; R Lorente-Omeñaca; B Cabrera; A Lobo; A M González-Pinto; J Merchán-Naranjo; I Corripio; E Vieta; E de la Serna; A Butjosa; F Contreras; S Sarró; G Mezquida; M Ribeiro; M Bernardo; M J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-21       Impact factor: 5.270

5.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

6.  A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery.

Authors:  Herbert Y Meltzer; Min Young Sim; Adam Anderson; Christopher Cannistraci; Karu Jayathilake; Daniel Barrett Share; Myung Lee
Journal:  CNS Neurosci Ther       Date:  2018-07       Impact factor: 5.243

7.  Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions.

Authors:  Claudia Pisanu; Donatella Congiu; Giovanni Severino; Raffaella Ardau; Caterina Chillotti; Maria Del Zompo; Bernhard T Baune; Alessio Squassina
Journal:  Neuropsychopharmacology       Date:  2021-05-25       Impact factor: 8.294

8.  Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium.

Authors:  Jason Smucny; Deanna M Barch; James M Gold; Milton E Strauss; Angus W MacDonald; Megan A Boudewyn; J Daniel Ragland; Steven M Silverstein; Cameron S Carter
Journal:  Schizophr Res       Date:  2019-01-28       Impact factor: 4.939

Review 9.  Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety.

Authors:  István Laszlovszky; Ágota Barabássy; György Németh
Journal:  Adv Ther       Date:  2021-06-06       Impact factor: 3.845

10.  A Systematic Review of Cognition-Brain Morphology Relationships on the Schizophrenia-Bipolar Disorder Spectrum.

Authors:  James A Karantonis; Sean P Carruthers; Susan L Rossell; Christos Pantelis; Matthew Hughes; Cassandra Wannan; Vanessa Cropley; Tamsyn E Van Rheenen
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.